NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 47 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $122,000 | +76.8% | 15,000 | 0.0% | 0.08% | +54.5% |
| Q2 2016 | $69,000 | +9.5% | 15,000 | 0.0% | 0.06% | +1.9% |
| Q1 2016 | $63,000 | -45.7% | 15,000 | 0.0% | 0.05% | -47.6% |
| Q4 2015 | $116,000 | -40.5% | 15,000 | 0.0% | 0.10% | -46.6% |
| Q3 2015 | $195,000 | -14.1% | 15,000 | 0.0% | 0.19% | +0.5% |
| Q2 2015 | $227,000 | – | 15,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|